ID   SEES1
AC   CVCL_1Q89
SY   SEES-1; SEi-iku Embryonic Stem-1
DR   RCB; HES0006
DR   SKIP; SKIP001146
DR   Wikidata; Q54952773
RX   PubMed=31245438;
RX   PubMed=31245498;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Omics: Deep exome analysis.
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 17-03-22; Version: 7
//
RX   PubMed=31245438; DOI=10.1016/j.reth.2014.12.004;
RA   Akutsu H., Machida M., Kanzaki S., Sugawara T., Ohkura T., Nakamura N.,
RA   Yamazaki-Inoue M., Miura T., Vemuri M.C., Rao M.S., Miyado K.,
RA   Umezawa A.;
RT   "Xenogeneic-free defined conditions for derivation and expansion of
RT   human embryonic stem cells with mesenchymal stem cells.";
RL   Regen. Ther. 1:18-29(2015).
//
RX   PubMed=31245498; DOI=10.1016/j.reth.2016.06.003;
RA   Akutsu H., Nasu M., Morinaga S., Motoyama T., Homma N., Machida M.,
RA   Yamazaki-Inoue M., Okamura K., Nakabayashi K., Takada S., Nakamura N.,
RA   Kanzaki S., Hata K., Umezawa A.;
RT   "In vivo maturation of human embryonic stem cell-derived teratoma over
RT   time.";
RL   Regen. Ther. 5:31-39(2016).
//
RX   PubMed=33225099; DOI=10.31662/jmaj.2018-0029;
RA   Umezawa A., Sato Y., Kusakawa S., Amagase R., Akutsu H., Nakamura K.,
RA   Kasahara M., Matsubara Y., Igarashi T.;
RT   "Research and development strategy for future embryonic stem cell-
RT   based therapy in Japan.";
RL   JMA J. 3:287-294(2020).
//